Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease

NCT02408744 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Fibrosis
Chronic Kidney Disease

Interventions

DRUG: Pirfenidone

Sponsor

University of Guadalajara

Collaborators

[object Object]